Cargando…

Benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience

BACKGROUND: The use of left ventricular assist devices (LVADs) has gained significant importance for treatment of end-stage heart failure. Fast-track procedures are well established in cardiac surgery, whereas knowledge of their benefits after LVAD implantation is sparse. We hypothesized that ultra-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zayat, Rashad, Menon, Ares K., Goetzenich, Andreas, Schaelte, Gereon, Autschbach, Ruediger, Stoppe, Christian, Simon, Tim-Philipp, Tewarie, Lachmandath, Moza, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299681/
https://www.ncbi.nlm.nih.gov/pubmed/28179009
http://dx.doi.org/10.1186/s13019-017-0573-9
_version_ 1782506072903254016
author Zayat, Rashad
Menon, Ares K.
Goetzenich, Andreas
Schaelte, Gereon
Autschbach, Ruediger
Stoppe, Christian
Simon, Tim-Philipp
Tewarie, Lachmandath
Moza, Ajay
author_facet Zayat, Rashad
Menon, Ares K.
Goetzenich, Andreas
Schaelte, Gereon
Autschbach, Ruediger
Stoppe, Christian
Simon, Tim-Philipp
Tewarie, Lachmandath
Moza, Ajay
author_sort Zayat, Rashad
collection PubMed
description BACKGROUND: The use of left ventricular assist devices (LVADs) has gained significant importance for treatment of end-stage heart failure. Fast-track procedures are well established in cardiac surgery, whereas knowledge of their benefits after LVAD implantation is sparse. We hypothesized that ultra-fast-track anesthesia (UFTA) with in-theater extubation or at a maximum of 4 h. after surgery is feasible in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) level 3 and 4 patients and might prevent postoperative complications. METHODS: From March, 2010 to March, 2012, 53 LVADs (50 Heart Mate II and 3 Heart Ware) were implanted in patients in our department. UFTA was successfully performed (LVAD(ultra)) in 13 patients. After propensity score matching, we compared the LVAD(ultra) group with a matched group (LVAD(match)) receiving conventional anesthesia management. RESULTS: Patients in the LVAD(ultra) group had significantly lower incidences of pneumonia (p = 0.031), delirium (p = 0.031) and right ventricular failure (RVF) (p = 0.031). They showed a significantly higher cardiac index in the first 12 h. (p = 0.017); a significantly lower central venous pressure during the first 24 h. postoperatively (p = 0.005) and a significantly shorter intensive care unit (ICU) stay (p = 0.016). Kaplan-Meier analysis after four years of follow-up showed no significant difference in survival. CONCLUSION: In this pilot study, we demonstrated the feasibility of ultra-fast-track anesthesia in LVAD implantation in selected patients with INTERMACS level 3–4. Patients had a lower incidence of postoperative complications, better hemodynamic performance, shorter length of ICU stay and lower incidence of RVF after UFTA. Prospective randomized investigations should examine the preservation of right ventricular function in larger numbers and identify appropriate selection criteria. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13019-017-0573-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5299681
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52996812017-02-13 Benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience Zayat, Rashad Menon, Ares K. Goetzenich, Andreas Schaelte, Gereon Autschbach, Ruediger Stoppe, Christian Simon, Tim-Philipp Tewarie, Lachmandath Moza, Ajay J Cardiothorac Surg Research Article BACKGROUND: The use of left ventricular assist devices (LVADs) has gained significant importance for treatment of end-stage heart failure. Fast-track procedures are well established in cardiac surgery, whereas knowledge of their benefits after LVAD implantation is sparse. We hypothesized that ultra-fast-track anesthesia (UFTA) with in-theater extubation or at a maximum of 4 h. after surgery is feasible in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) level 3 and 4 patients and might prevent postoperative complications. METHODS: From March, 2010 to March, 2012, 53 LVADs (50 Heart Mate II and 3 Heart Ware) were implanted in patients in our department. UFTA was successfully performed (LVAD(ultra)) in 13 patients. After propensity score matching, we compared the LVAD(ultra) group with a matched group (LVAD(match)) receiving conventional anesthesia management. RESULTS: Patients in the LVAD(ultra) group had significantly lower incidences of pneumonia (p = 0.031), delirium (p = 0.031) and right ventricular failure (RVF) (p = 0.031). They showed a significantly higher cardiac index in the first 12 h. (p = 0.017); a significantly lower central venous pressure during the first 24 h. postoperatively (p = 0.005) and a significantly shorter intensive care unit (ICU) stay (p = 0.016). Kaplan-Meier analysis after four years of follow-up showed no significant difference in survival. CONCLUSION: In this pilot study, we demonstrated the feasibility of ultra-fast-track anesthesia in LVAD implantation in selected patients with INTERMACS level 3–4. Patients had a lower incidence of postoperative complications, better hemodynamic performance, shorter length of ICU stay and lower incidence of RVF after UFTA. Prospective randomized investigations should examine the preservation of right ventricular function in larger numbers and identify appropriate selection criteria. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13019-017-0573-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-08 /pmc/articles/PMC5299681/ /pubmed/28179009 http://dx.doi.org/10.1186/s13019-017-0573-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zayat, Rashad
Menon, Ares K.
Goetzenich, Andreas
Schaelte, Gereon
Autschbach, Ruediger
Stoppe, Christian
Simon, Tim-Philipp
Tewarie, Lachmandath
Moza, Ajay
Benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience
title Benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience
title_full Benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience
title_fullStr Benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience
title_full_unstemmed Benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience
title_short Benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience
title_sort benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299681/
https://www.ncbi.nlm.nih.gov/pubmed/28179009
http://dx.doi.org/10.1186/s13019-017-0573-9
work_keys_str_mv AT zayatrashad benefitsofultrafasttrackanesthesiainleftventricularassistdeviceimplantationaretrospectivepropensityscorematchedcohortstudyofafouryearsinglecenterexperience
AT menonaresk benefitsofultrafasttrackanesthesiainleftventricularassistdeviceimplantationaretrospectivepropensityscorematchedcohortstudyofafouryearsinglecenterexperience
AT goetzenichandreas benefitsofultrafasttrackanesthesiainleftventricularassistdeviceimplantationaretrospectivepropensityscorematchedcohortstudyofafouryearsinglecenterexperience
AT schaeltegereon benefitsofultrafasttrackanesthesiainleftventricularassistdeviceimplantationaretrospectivepropensityscorematchedcohortstudyofafouryearsinglecenterexperience
AT autschbachruediger benefitsofultrafasttrackanesthesiainleftventricularassistdeviceimplantationaretrospectivepropensityscorematchedcohortstudyofafouryearsinglecenterexperience
AT stoppechristian benefitsofultrafasttrackanesthesiainleftventricularassistdeviceimplantationaretrospectivepropensityscorematchedcohortstudyofafouryearsinglecenterexperience
AT simontimphilipp benefitsofultrafasttrackanesthesiainleftventricularassistdeviceimplantationaretrospectivepropensityscorematchedcohortstudyofafouryearsinglecenterexperience
AT tewarielachmandath benefitsofultrafasttrackanesthesiainleftventricularassistdeviceimplantationaretrospectivepropensityscorematchedcohortstudyofafouryearsinglecenterexperience
AT mozaajay benefitsofultrafasttrackanesthesiainleftventricularassistdeviceimplantationaretrospectivepropensityscorematchedcohortstudyofafouryearsinglecenterexperience